Brazil Clinical Decision Support Systems Market Size & Outlook
Global Market
Related Markets
Brazil clinical decision support systems market highlights
- The Brazil clinical decision support systems market generated a revenue of USD 102.3 million in 2025 and is expected to reach USD 300.8 million by 2033.
- The Brazil market is expected to grow at a CAGR of 14.6% from 2026 to 2033.
- In terms of segment, standalone cdss was the largest revenue generating product in 2025.
- Integrated EHR with CDSS is the most lucrative product segment registering the fastest growth during the forecast period.
Clinical decision support systems market data book summary
| Market revenue in 2025 | USD 102.3 million |
| Market revenue in 2033 | USD 300.8 million |
| Growth rate | 14.6% (CAGR from 2026 to 2033) |
| Largest segment | Standalone cdss |
| Fastest growing segment | Integrated EHR with CDSS |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Standalone CDSS, Integrated CPOE with CDSS, Integrated EHR with CDSS, Integrated CDSS with CPOE and EHR |
| Key market players worldwide | McKesson Corp, Oracle Corp, Siemens Healthineers AG ADR, Allscripts Healthcare, NextGen Healthcare, Koninklijke Philips NV, International Business Machines Corp, Agfa-Gevaert NV, Wolters Kluwer NV, Athenahealth |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.6% of the global clinical decision support systems market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Latin America, Brazil clinical decision support systems market is projected to lead the regional market in terms of revenue in 2033.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 300.8 million by 2033.
Major drivers expected to propel Brazil’s CDSS market include increasing incidence of chronic diseases. According to NCBI, in Brazil, an estimated 928,000 deaths occurred due to chronic disease in 2020, and the high prevalence of overweight in the country is a major cause of these deaths.
The drug databases and diagnostic decision support segment is expected to account for the leading market share during the forecast period. This can be attributed to advantages such as multitasking, enhanced appointment scheduling, patient communication, providing hassle-free billing & insurance claiming, and patient charting to streamline daily workflow.
The various benefits available with drug databases, care plans, and diagnostic decision support applications are expected to contribute to CDSS market growth in Brazil.
No credit card required*
Publish Date: May 14, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Clinical Decision Support Systems Market Scope
Clinical Decision Support Systems Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Oracle Corp | View profile | 164,000 | 2300 Oracle Way, Austin, TX, United States, 78741 | www.oracle.com |
| Koninklijke Philips NV | View profile | 73,712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | www.philips.com |
| International Business Machines Corp | View profile | 282,200 | One New Orchard Road, Armonk, NY, United States, 10504 | www.ibm.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| McKesson Corp | View profile | 51,000 | 6555 State Highway 161, Irving, TX, United States, 75039 | www.mckesson.com |
| Agfa-Gevaert NV | View profile | 7,000 | Septestraat 27, Mortsel, Belgium, B-2640 | www.agfa.com |
| Wolters Kluwer NV | View profile | 21,400 | Zuidpoolsingel 2, P.O. Box 1030, Alphen aan den Rijn, ZH, Netherlands, 2400 | www.wolterskluwer.com |
| Allscripts Healthcare | View profile | - | - | - |
| NextGen Healthcare | View profile | 1001-5000 | Irvine, California, United States, North America | www.nextgen.com |
| Athenahealth | View profile | 5001-10000 | Watertown, Massachusetts, United States, North America | www.athenahealth.com |
Brazil Clinical Decision Support Systems Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Clinical Decision Support Systems Market Outlook will help companies and investors design strategic landscapes.
Standalone Cdss was the largest segment with a revenue share of 34.31% in 2025.
Horizon Databook has segmented the Brazil clinical decision support systems market based on standalone cdss, integrated cpoe with cdss, integrated ehr with cdss, integrated cdss with cpoe and ehr covering the revenue growth of each sub-segment from 2021 to 2033.
Major drivers expected to propel Brazil’s CDSS market include increasing incidence of chronic diseases. According to NCBI, in Brazil, an estimated 928,000 deaths occurred due to chronic disease in 2020, and the high prevalence of overweight in the country is a major cause of these deaths.
The drug databases and diagnostic decision support segment is expected to account for the leading market share during the forecast period. This can be attributed to advantages such as multitasking, enhanced appointment scheduling, patient communication, providing hassle-free billing & insurance claiming, and patient charting to streamline daily workflow.
The various benefits available with drug databases, care plans, and diagnostic decision support applications are expected to contribute to CDSS market growth in Brazil.
- Brazil Clinical Decision Support Systems Market Product Outlook (Revenue, USD Million , 2021-2033)
- Standalone CDSS
- Integrated CPOE with CDSS
- Integrated EHR with CDSS
- Integrated CDSS with CPOE and EHR
- Brazil Clinical Decision Support Systems Market Application Outlook (Revenue, USD Million , 2021-2033)
- Drug-Drug Interactions
- Drug Allergy Alerts
- Clinical Reminders
- Clinical Guidelines
- Drug Dosing Support
- Others
- Brazil Clinical Decision Support Systems Market Delivery Mode Outlook (Revenue, USD Million , 2021-2033)
- Web-Based Systems
- Cloud-Based Systems
- On-Premise Systems
- Brazil Clinical Decision Support Systems Market Component Outlook (Revenue, USD Million , 2021-2033)
- Hardware
- Software
- Services
Reasons to subscribe to Clinical Decision Support Systems Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Clinical Decision Support Systems Market Outlook databook
- Our clientele includes a mix of Clinical Decision Support Systems Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil Clinical Decision Support Systems Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Brazil Clinical Decision Support Systems Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Brazil Clinical Decision Support Systems Market, 2021-2033 (US$M)
Brazil Product - Clinical Decision Support Systems Market Statistics, 2025 - 2033 (US$M)
